Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Ocul Pharmacol Ther ; 26(4): 315-8, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20698796

RESUMEN

PURPOSE: The aim of this study was to evaluate the safety of moxifloxacin and voriconazole as a supplement in corneal storage media for porcine corneal endothelial cells. METHODS: Twenty-eight eyes were divided into 4 groups. In the control group (the C group), corneal buttons were stored for 3 days in Optisol-GS. In the treatment group, the corneal buttons were preserved for 3 days in Optisol-GS mixed with 250 microg/mL moxifloxacin (M group), 100 microg/mL voriconazole (V group), and 250 microg/mL moxifloxacin plus 100 microg/mL voriconazole (MV group). We evaluated the samples via specular microscopy before and after 3 days of preservation. The mean changes of endothelial cell counts were compared among the 4 groups. Scanning electron microscopy was conducted after 3 days of preservation. RESULTS: Before the preservation, the endothelial cell counts did not differ among the 4 groups (P > 0.05). After 3 days of preservation, the endothelial cell count in the MV group was the lowest among the 4 groups (P < 0.05). After 3 days of preservation, the rate of corneal endothelial cell loss in the M and V groups did not differ significantly from the control group (P > 0.05). The rate of endothelial cell loss in the MV group was significantly higher than that of the control group (P < 0.05). Scanning electron microscopy revealed a normal mosaic pattern for the C, V, and F groups, but hexagonality was not preserved in the MV group. CONCLUSION: Preservation in Optisol-GS mixed with moxifloxacin (250 microg/mL) plus voriconazole (100 microg/mL) induced significant toxicity on the endothelial cells in porcine corneas, when compared with the control group.


Asunto(s)
Antiinfecciosos/toxicidad , Compuestos Aza/toxicidad , Sulfatos de Condroitina , Dextranos , Endotelio Corneal/efectos de los fármacos , Gentamicinas , Soluciones Preservantes de Órganos , Pirimidinas/toxicidad , Quinolinas/toxicidad , Conservación de Tejido , Triazoles/toxicidad , Animales , Antiinfecciosos/metabolismo , Antiinfecciosos/uso terapéutico , Compuestos Aza/metabolismo , Compuestos Aza/uso terapéutico , Recuento de Células , Supervivencia Celular/efectos de los fármacos , Mezclas Complejas , Córnea/efectos de los fármacos , Criopreservación , Medio de Cultivo Libre de Suero , Endotelio Corneal/citología , Fluoroquinolonas , Moxifloxacino , Pirimidinas/metabolismo , Pirimidinas/uso terapéutico , Quinolinas/metabolismo , Quinolinas/uso terapéutico , Porcinos , Triazoles/metabolismo , Triazoles/uso terapéutico , Voriconazol
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA